There is a strong relationship between smoking and cardiovascular diseases where smoking is in all the symptoms and heart problems, including: - infarction heart muscle and coronary artery disease, angina and chest, sudden death and artery disease and vascular Aorta terminal.
The study indicates that people are limited to non-smokers live longer duration (2-6) years for men, (4-9) years for women.
For persons from non-smokers and have history of heart patients live for two
(2-4) years for men and (2-7) years for women compared to non-smokers in persons.
Smoking is the direct cause of the spread of cardiovascular diseases and also that smoking is to raise the level of cholesterol in the blood, which is with smoking because of another illness infarction heart muscle as well.
The study suggests that the danger of smoking continues even if the quantity of cigarettes less (1-4 cigarettes), where the discovery was that these cigarettes enough to cause cardiovascular disease and coronary deadly to increase vulnerability, especially among women.
The gravity of continue smoking cigarettes in filtered or that contain less than the rates of nicotine and tar and carbon monoxide because the smoker is taking the same deep and continuing this cause clogging ventilation holes in the filter Alsjarh.
It was discovered that the seriousness of smoking in middle age or more on the elderly and find that compared to coronary artery disease have a rate of (2:1) when smokers who do not exceed the age of 50 years and the ratio (5:1) of smokers who went beyond this age.
The lower rate of major heart disease after smoking cessation in the first three years to reach the proportion of natural when non-smokers after about (10-15) years.
The percentage of fatal coronary heart disease by less (36%) in smoking cessation.
therapies available to stop smoking: --
Fail majority of smokers to stop smoking for more than a few days and there are less than (5%) of smokers stop smoking for more than a year.
Has been increased chance of stopping smoking after addressing treatments for this assistance, including: --
-- Substitution treatment for nicotine NRT is available and numerous photographs of them (your comments, to the maximum, traps nose, inhalers, capsule under the tongue).
-- Albobrobion Bupropion:
The two first-line therapy in the treatment:
1. Substitution treatment for nicotine: this treatment readily available and can be used for people living with cardiovascular disease and begin treatment in the first day of interruption or a day earlier in the case Plasters Alnecotiinet.
2. Real estate Albobrobion Bupropion: use of anti-depression and helps increase Alnoradarialin and Aldobambin in the central nervous system, which helps to stop smoking and the impact of stronger than substitution treatment, but there are limited for use by (3:1) and smokers are often dose 150 mg to 300 mg dose and less when people who Epilepsy treatments using the property is security for heart patients and have to stop from (8-13) day after the use of medications and therapy is nicotine substitution came after Alberobion second option are the first line in dealing with smoking.
new treatments to stop smoking: --
-- Rimunbant Albulaspo Rimonabant or placebo: - working to discourage nicotine receptors in the nervous system and is available dose of 5 mg / day, 20 Mjeram / day treatment period and more than (4) weeks and be treated proportion (16%) dose of 5 mg / day of Albulaspo placebo and increase by ( 28%) dose of 20 mg / day, and used the drug in the treatment of obesity expected after stopping smoking.
-- Vaccines for nicotine Nicotin vaccines: - prevents link nicotine found in cigarettes with nicotine receptors in the brain, but these antibodies generated in the body does not last long and that these vaccines are not available in some cases.
-- Franklin Vareni cline: - real estate through the mouth associated with neurological receptors known as α 4 β2 Nicotin Actylcholin reception receptors are important for an addiction and the drug discourage these receptors and stimulate the release of dopamine (35-60%) and this is sufficient to change the behaviour of animals and non-enforceability of nicotine.
Figure rate during the last stop (4) weeks after treatment with drugs to stop smoking for seven weeks.
Conclusion: --
-- Stop smoking depends on the partnership between pharmacological treatment and the role of psychological and social.
-- Even now widely used treatment Balbobrobion substitution therapy for nicotine.
-- Alfarnkellen new property has been registered by the Commission and the European medicines evaluation of America EMEA, US FDA are described in Britain has shown greater effectiveness and safety of high Bobrobion which causes headache, anxiety, and dry mouth.
-- So far there is no risk from using Franklin on cardiovascular diseases.
-- Efforts are still ongoing and studies of medical treatments and support necessary to stop smoking.
-- Finally, requires the physician to follow the new state of the smoker and follow-up studies on this.
A copy of the scientific article published in the British Journal of Cardiology / Middle East
Writer: Serena Tonstad
Dr. interpretation / Najeeb Al Buraiki doctor clinic Charity Society to combat smoking in Riyadh
The study indicates that people are limited to non-smokers live longer duration (2-6) years for men, (4-9) years for women.
For persons from non-smokers and have history of heart patients live for two
(2-4) years for men and (2-7) years for women compared to non-smokers in persons.
Smoking is the direct cause of the spread of cardiovascular diseases and also that smoking is to raise the level of cholesterol in the blood, which is with smoking because of another illness infarction heart muscle as well.
The study suggests that the danger of smoking continues even if the quantity of cigarettes less (1-4 cigarettes), where the discovery was that these cigarettes enough to cause cardiovascular disease and coronary deadly to increase vulnerability, especially among women.
The gravity of continue smoking cigarettes in filtered or that contain less than the rates of nicotine and tar and carbon monoxide because the smoker is taking the same deep and continuing this cause clogging ventilation holes in the filter Alsjarh.
It was discovered that the seriousness of smoking in middle age or more on the elderly and find that compared to coronary artery disease have a rate of (2:1) when smokers who do not exceed the age of 50 years and the ratio (5:1) of smokers who went beyond this age.
The lower rate of major heart disease after smoking cessation in the first three years to reach the proportion of natural when non-smokers after about (10-15) years.
The percentage of fatal coronary heart disease by less (36%) in smoking cessation.
therapies available to stop smoking: --
Fail majority of smokers to stop smoking for more than a few days and there are less than (5%) of smokers stop smoking for more than a year.
Has been increased chance of stopping smoking after addressing treatments for this assistance, including: --
-- Substitution treatment for nicotine NRT is available and numerous photographs of them (your comments, to the maximum, traps nose, inhalers, capsule under the tongue).
-- Albobrobion Bupropion:
The two first-line therapy in the treatment:
1. Substitution treatment for nicotine: this treatment readily available and can be used for people living with cardiovascular disease and begin treatment in the first day of interruption or a day earlier in the case Plasters Alnecotiinet.
2. Real estate Albobrobion Bupropion: use of anti-depression and helps increase Alnoradarialin and Aldobambin in the central nervous system, which helps to stop smoking and the impact of stronger than substitution treatment, but there are limited for use by (3:1) and smokers are often dose 150 mg to 300 mg dose and less when people who Epilepsy treatments using the property is security for heart patients and have to stop from (8-13) day after the use of medications and therapy is nicotine substitution came after Alberobion second option are the first line in dealing with smoking.
new treatments to stop smoking: --
-- Rimunbant Albulaspo Rimonabant or placebo: - working to discourage nicotine receptors in the nervous system and is available dose of 5 mg / day, 20 Mjeram / day treatment period and more than (4) weeks and be treated proportion (16%) dose of 5 mg / day of Albulaspo placebo and increase by ( 28%) dose of 20 mg / day, and used the drug in the treatment of obesity expected after stopping smoking.
-- Vaccines for nicotine Nicotin vaccines: - prevents link nicotine found in cigarettes with nicotine receptors in the brain, but these antibodies generated in the body does not last long and that these vaccines are not available in some cases.
-- Franklin Vareni cline: - real estate through the mouth associated with neurological receptors known as α 4 β2 Nicotin Actylcholin reception receptors are important for an addiction and the drug discourage these receptors and stimulate the release of dopamine (35-60%) and this is sufficient to change the behaviour of animals and non-enforceability of nicotine.
Figure rate during the last stop (4) weeks after treatment with drugs to stop smoking for seven weeks.
Conclusion: --
-- Stop smoking depends on the partnership between pharmacological treatment and the role of psychological and social.
-- Even now widely used treatment Balbobrobion substitution therapy for nicotine.
-- Alfarnkellen new property has been registered by the Commission and the European medicines evaluation of America EMEA, US FDA are described in Britain has shown greater effectiveness and safety of high Bobrobion which causes headache, anxiety, and dry mouth.
-- So far there is no risk from using Franklin on cardiovascular diseases.
-- Efforts are still ongoing and studies of medical treatments and support necessary to stop smoking.
-- Finally, requires the physician to follow the new state of the smoker and follow-up studies on this.
A copy of the scientific article published in the British Journal of Cardiology / Middle East
Writer: Serena Tonstad
Dr. interpretation / Najeeb Al Buraiki doctor clinic Charity Society to combat smoking in Riyadh
0 Comments